The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The discovery of nitric oxide as the endogenous nitrovasodilator.
Abstract
Endothelium-derived relaxing factor (EDRF) is a labile humoral agent released by vascular endothelium that mediates the relaxation induced by some vasodilators, including acetylcholine and bradykinin. EDRF also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to vascular endothelium. These actions of EDRF are mediated through stimulation of the soluble guanylate cyclase and the consequent elevation of cyclic guanosine 3',5'-monophosphate. EDRF has been identified as nitric oxide (NO). The pharmacology of NO and EDRF is indistinguishable; furthermore, sufficient NO is released from endothelial cells to account for the biological activities of EDRF. Organic nitrates exert their vasodilator activity following conversion to NO in vascular smooth muscle cells. Thus, NO may be considered the endogenous nitrovasodilator. NO is synthesized by vascular endothelium from the terminal guanido nitrogen atom(s) of the amino acid L-arginine. This indicates the existence of an enzymic pathway in which L-arginine is the endogenous precursor for the synthesis of NO. The discovery of the release of NO by vascular endothelial cells, the biosynthetic pathway leading to its generation, and its interaction with other vasoactive substances opens up new avenues for research into the physiology and pathophysiology of the vessel wall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Self-citationEndothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769
Self-citationMoncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Self-citationSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Self-citationRole of endothelium in responses of vascular smooth muscle.
Furchgott, R. F. (1983) · Circulation Research · doi:10.1161/01.res.53.5.557 · Cited by 1,949
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite
Hibbs, J. B., Taintor, R. R., & Vavrin, Z. (1987) · Science · doi:10.1126/science.2432665 · Cited by 1,527
ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91481-4 · Cited by 1,437
Self-citation
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Peroxynitrite oxidation of sulfhydryls.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,490
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Self-citationNitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Biosynthesis of nitric oxide from l-arginine
Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90403-6 · Cited by 1,208
Self-citationGuanylate cyclase and the ⋅NO/cGMP signaling pathway
Denninger, J. W., & Marletta, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00024-9 · Cited by 1,040
Endothelium-dependent vasodilation is attenuated in patients with heart failure.
Kubo, S. H., Rector, T. S., Bank, A. J., Williams, R. E., & Heifetz, S. M. (1991) · Circulation · doi:10.1161/01.cir.84.4.1589 · Cited by 775
Endogenous nitric oxide: physiology, pathology and clinical relevance
MONCADA, S., & HIGGS, E. A. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01383.x · Cited by 759
Self-citationBasic Principles and Emerging Concepts in the Redox Control of Transcription Factors
Brigelius-Flohé, R., & Flohé, L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3534 · Cited by 576
Endothelial dysfunction : the early predictor of atherosclerosis
Mudau, M., Genis, A., Lochner, A., & Strijdom, H. (2012) · Cardiovascular Journal of Africa · doi:10.5830/cvja-2011-068 · Cited by 521
Nitric oxide. A novel signal transduction mechanism for transcellular communication.
Ignarro, L. J. (1990) · Hypertension · doi:10.1161/01.hyp.16.5.477 · Cited by 499
Role of the circadian system in cardiovascular disease
Thosar, S. S., Butler, M. P., & Shea, S. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci80590 · Cited by 443
Control of regional blood flow by endothelium-derived nitric oxide.
Gardiner, S. M., Compton, A. M., Bennett, T., Palmer, R. M., & Moncada, S. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.486 · Cited by 436
Self-citationNitric oxide: biosynthesis and biological significance
Marletta, M. A. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90181-3 · Cited by 413
Lidder, S., & Webb, A. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04420.x · Cited by 360
Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol
Cooney, R. V., Franke, A. A., Harwood, P. J., Hatch-Pigott, V, Custer, L. J., & Mordan, L. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1771 · Cited by 343
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
de Graaf, J. C., Banga, J. D., Moncada, S., Palmer, R. M., de Groot, P. G., & Sixma, J. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2284 · Cited by 337
Self-citationPeripheral analgesia and activation of the nitric oxide-cyclic GMP pathway
Duarte, I. D. G., Lorenzetti, B. B., & Ferreira, S. H. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90446-d · Cited by 315
Pain and analgesia: The dual effect of nitric oxide in the nociceptive system
Cury, Y., Picolo, G., Gutierrez, V. P., & Ferreira, S. H. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.06.004 · Cited by 315
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Toda, N., & Okamura, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.3 · Cited by 308
Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide
de la Torre, J. C., & Stefano, G. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00043-6 · Cited by 308
Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology
Tuteja, N., Chandra, M., Tuteja, R., & Misra, M. K. (2004) · BioMed Research International · doi:10.1155/s1110724304402034 · Cited by 269
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.
Dohi, Y., Thiel, M. A., Bühler, F. R., & Lüscher, T. F. (1990) · Hypertension · doi:10.1161/01.hyp.16.2.170 · Cited by 252
Joyner, M. J., Dietz, N. M., & Shepherd, J. T. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.6.2431 · Cited by 177
Gilchrist, M., Winyard, P. G., & Benjamin, N. (2010) · Nitric Oxide · doi:10.1016/j.niox.2009.10.005 · Cited by 157
Bailey, S. J., Winyard, P. G., Vanhatalo, A., Blackwell, J. R., DiMenna, F. J., Wilkerson, D. P., & Jones, A. M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00503.2010 · Cited by 132
L-Arginine is a precursor for nitrate biosynthesis in humans
Leaf, C. D., Wishnok, J. S., & Tannenbaum, S. R. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92325-5 · Cited by 129
Nitric oxide deficiency is a primary driver of hypertension
Bryan, N. S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115325 · Cited by 77
Kerley, C. P., Cahill, K., Bolger, K., McGowan, A., Burke, C., Faul, J., & Cormican, L. (2015) · Nitric Oxide · doi:10.1016/j.niox.2014.12.010 · Cited by 69
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Triggle, C. R., Ding, H., Marei, I., Anderson, T. J., & Hollenberg, M. D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0677 · Cited by 49
Prostacyclin, high density lipoproteins, and myocardial ischemia.
Lefer, A. M. (1990) · Circulation · doi:10.1161/01.cir.81.6.2013 · Cited by 33
Vasopressin in Vasodilatory Shock
Ukor, I.-F., & Walley, K. R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.004 · Cited by 27
Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5
Cai, Z., Yuan, S., Zhong, Y., Deng, L., Li, J., Tan, X., & Feng, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637051 · Cited by 23
Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.014 · Cited by 20
Nowak, A., Szymańska, A., Kwaśniewska, M., Kochan, E., & Lipert, A. (2025) · Nutrients · doi:10.3390/nu17243954 · Cited by 5
Metadata
- Authors
- Moncada, S., Palmer, R. M., & Higgs, E. A.
- Venue
- Hypertension
- Published
- 1988-10
- Volume
- 12
- Issue
- 4
- Pages
- 365-372
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2073497750
- Cited by
- 492
- References
- 55
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.